Rare Classroom: Acromegaly
source: shutterstock

Rare Classroom: Acromegaly

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Acromegaly
Oral Octreotide Approved to Treat Acromegaly
source: pixabay.com

Oral Octreotide Approved to Treat Acromegaly

As shared in Medscape, the FDA recently approved oral octreotide (Mycapssa) for the treatment of patients with acromegaly. These delayed-release capsules are the first approved oral somatostatin analog ever approved.…

Continue Reading Oral Octreotide Approved to Treat Acromegaly
Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA
source: pixabay.com

Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA

On April 28th, 2020, Acromegaly Community, a nonprofit organization that is dedicated to supporting acromegaly patients, will be hosting a patient focused drug development meeting (PFDD). These meetings are an…

Continue Reading Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA
The IND Approval From The FDA, Experimental Acromegaly Drug Will Enter Phase 3 Trials
peter-facebook / Pixabay

The IND Approval From The FDA, Experimental Acromegaly Drug Will Enter Phase 3 Trials

According to a story from Markets Insider, the biopharmaceutical company Camurus has recently issued an announcement indicating that the US Food and Drug Administration (FDA) has accepted the company's Investigational…

Continue Reading The IND Approval From The FDA, Experimental Acromegaly Drug Will Enter Phase 3 Trials